Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms

@article{Gentile2015EarlyPE,
  title={Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms},
  author={S. Gentile},
  journal={Expert Opinion on Drug Metabolism & Toxicology},
  year={2015},
  volume={11},
  pages={1585 - 1597}
}
  • S. Gentile
  • Published 2015
  • Medicine
  • Expert Opinion on Drug Metabolism & Toxicology
  • Introduction: Selective serotonin reuptake inhibitors (SSRIs) are commonly used to manage antenatal depression. Hence, the aim of this systematic review is to assess the prevalence of birth defects associated with pregnancy exposure to such agents and summarize the hypothesized teratogenic mechanisms. Areas covered: Medical literature published in English (1980 – June 2015) was electronically searched to identify all articles reporting an increased prevalence of birth defects associated with… CONTINUE READING
    16 Citations
    Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis
    • 5
    Fluoxetine and congenital malformations: a systematic review and meta‐analysis of cohort studies
    • 26
    Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU
    Depression During Pregnancy and Postpartum
    • 33

    References

    SHOWING 1-10 OF 103 REFERENCES
    Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study
    • 106
    • Highly Influential
    • PDF
    Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
    • 259
    Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
    • 183
    • Highly Influential
    Sertraline use during pregnancy and the risk of major malformations.
    • 45
    • Highly Influential
    Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
    • 223
    • Highly Influential
    • PDF
    Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis
    • 109
    • Highly Influential
    • PDF
    First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
    • 406
    • Highly Influential
    • PDF